Kinloch Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
24,158
+833
| +4% | +$155K | 2.09% | 8 |
|
|
2025
Q1 | $4.89M | Buy |
23,325
+4,002
| +21% | +$838K | 2.34% | 5 |
|
|
2024
Q4 | $3.43M | Buy |
19,323
+777
| +4% | +$138K | 1.72% | 31 |
|
|
2024
Q3 | $3.66M | Sell |
18,546
-445
| -2% | -$87.9K | 1.78% | 28 |
|
|
2024
Q2 | $3.26M | Sell |
18,991
-74
| -0.4% | -$12.7K | 1.7% | 28 |
|
|
2024
Q1 | $3.47M | Buy |
19,065
+1,260
| +7% | +$229K | 1.78% | 32 |
|
|
2023
Q4 | $2.76M | Sell |
17,805
-480
| -3% | -$74.4K | 1.75% | 31 |
|
|
2023
Q3 | $2.73M | Sell |
18,285
-292
| -2% | -$43.5K | 1.71% | 32 |
|
|
2023
Q2 | $2.5M | Sell |
18,577
-301
| -2% | -$40.6K | 1.49% | 38 |
|
|
2023
Q1 | $3.01M | Sell |
18,878
-13,550
| -42% | -$2.16M | 1.76% | 32 |
|
|
2022
Q4 | $5.24M | Buy |
32,428
+914
| +3% | +$148K | 3.05% | 4 |
|
|
2022
Q3 | $4.23M | Buy |
31,514
+209
| +0.7% | +$28K | 2.79% | 3 |
|
|
2022
Q2 | $4.8M | Buy |
31,305
+1,133
| +4% | +$174K | 3.09% | 2 |
|
|
2022
Q1 | $4.89M | Buy |
30,172
+1,196
| +4% | +$194K | 2.93% | 3 |
|
|
2021
Q4 | $3.92M | Buy |
28,976
+7,209
| +33% | +$976K | 2.43% | 6 |
|
|
2021
Q3 | $2.35M | Buy |
21,767
+2,196
| +11% | +$237K | 1.66% | 31 |
|
|
2021
Q2 | $2.2M | Buy |
19,571
+387
| +2% | +$43.6K | 1.58% | 34 |
|
|
2021
Q1 | $2.08M | Buy |
19,184
+1,264
| +7% | +$137K | 1.59% | 38 |
|
|
2020
Q4 | $1.92M | Buy |
+17,920
| New | +$1.92M | 1.62% | 34 |
|